Study of how E2086 leaves the body in healthy men
This trial studies how a new drug, E2086, is processed and removed from the body in healthy men. It uses a radioactive tracer to track the drug, which helps researchers understand its safety and effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man aged 18 to 55
- You do not smoke or vape
- Your weight is in a healthy range (BMI between 18 and 30)
- You have not taken part in more than 2 other radioactive drug studies in the past year
- You have not had major radiation exposure in the past year (like many X-rays or CT scans)
- You are willing to use effective birth control or have had a vasectomy
- You have no serious medical conditions or recent surgeries that could affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new investigational drug called MRM-3379 in healthy men. It uses a tiny amount of a radioactive marker to track how the drug moves through the body, how it's broken down, and how it leaves. Participating helps researchers learn how to dose the drug safely in future studies.
This study looks at a new medicine called E2086 to see how it interacts with common medications in healthy adults. It is an early study to understand how the drug moves through and affects the body.
This study looks at how a new drug is processed by the body in healthy adults. It will help understand how the drug is absorbed, distributed, and eliminated.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This study looks at how a new drug (RAY1225) leaves the body after a single injection. It involves healthy volunteers to track the drug over time and understand its safety.
This study is for healthy men to see how the body processes an investigational drug called ASP3082. It is a first-in-human study, meaning it's one of the first times the drug is given to people, and the results will guide future research.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.